Thank you for joining us at ESID 2024, where we brought together over 2,500 colleagues from the global primary immunodeficiency (PID) community. Together we are furthering the knowledge in the field by shaping a high-quality educational programme and fostering indispensable cooperation among all those involved in the diagnosis, treatment, and management of PIDs.